Tag: topical drugs contract development and manufacturing organization (cdmo) market insights

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market from 2024 to 2033?
The topical drugs contract development and manufacturing organization (CDMO) market is expected to grow from $45.47 billion in 2023 to $52.9 billion in 2024, at a CAGR of 16.3%. This growth is linked to the prevalence of chronic diseases, advancements in drug delivery technologies, cost-effective outsourcing, regulatory pressures, and expansion in dermatology and cosmetics.

The topical drugs contract development and manufacturing organization (CDMO) market is expected to grow rapidly, reaching $97.26 billion by 2028 at a CAGR of 16.4%. This growth can be attributed to personalized medicine, expansion of biologics, increased R&D investments, rising skin disorder prevalence, and advancements in manufacturing technologies. Major trends include demand for innovative formulations, advancements in drug delivery technologies, increased investment in dermatological research, pharmaceutical outsourcing, and a focus on personalized medicine.

Claim Your Free Sample of the Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15942&type=smp

What Key Factors Are Fueling the Growth of the Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
The increasing incidence of skin diseases is expected to boost the topical drugs contract development and manufacturing organization (CDMO) market. Skin diseases involve conditions that cause inflammation, itching, and lesions, influenced by factors such as environmental pollution, UV exposure, and lifestyle changes. CDMOs develop targeted therapies to improve the management of dermatological conditions. For instance, a report from Cancer Australia indicated that skin melanoma cases rose from 15,628 to 18,257 between 2019 and 2023. Therefore, the growing prevalence of skin diseases is propelling the CDMO market’s growth.

What Are the Major Segments of the Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
1) By Product Type: Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products
2) By Service Type: Contract Development, Contract Manufacturing
3) By Therapeutic Area: Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas
4) By End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses

What New Trends Are Transforming the Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
Companies in the topical drugs CDMO market are building state-of-the-art manufacturing facilities to maintain competitiveness. In November 2023, SOHM Inc. launched a CDMO GMP facility in Carlsbad, designed for topical products with an initial daily capacity of 500 gallons, set to expand for soft-gel suppositories by mid-2024.

Order Now for Fast Delivery of Your Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report!
https://www.thebusinessresearchcompany.com/report/topical-drugs-contract-development-and-manufacturing-organization-cdmo-global-market-report

Which Regions Are Driving Growth in the Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
Asia-Pacific was the largest region in the topical drugs contract development and manufacturing organization (CDMO) market in 2023. The regions covered in the topical drugs contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the topical drugs contract development and manufacturing organization (cdmo) market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Include

1. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Executive Summary
2. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Segments
3. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Size And Template Market Growth Rate
4.  Key Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Trends
5. Major Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Drivers
……
25. Key Mergers And Acquisitions In The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market
26. Top Topical Drugs Contract Development And Manufacturing Organization (CDMO) Companies
27. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Opportunities And Strategies
28. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:
Topical Drug Delivery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/topical-drug-delivery-global-market-report

Topical Drug Delivery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/topical-drug-delivery-global-market-report

Peptide Synthesis Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Topical Drugs Contract Development And Manufacturing Organization (CDMO) Global Market Report 2024, the topical drugs contract development and manufacturing organization (CDMO) market is expected to show significant growth in the forecast period.

The topical drugs contract development and manufacturing organization (CDMO) market has experienced significant growth recently.

• Market Size and Growth:
  • Grew from $45.47 billion in 2023 to $52.9 billion in 2024, reflecting a CAGR of 16.3%.
  • Expected to reach $97.26 billion by 2028, with a CAGR of 16.4%.

Factors Driving Historic Growth
Several factors contributed to the market’s growth during the historic period.

• Chronic Disease Prevalence: Increased incidence of chronic skin conditions.
• Advanced Drug Delivery Technologies: Innovations in how drugs are delivered topically.
• Cost-Efficient Outsourcing: Pharmaceutical companies outsourcing to CDMOs for cost savings.
• Regulatory Demands: Stringent regulations requiring specialized manufacturing processes.
• Growth in Dermatology and Cosmetics: Rising demand for dermatological and cosmetic products.

Future Growth Drivers
The forecast period predicts continued robust growth due to several key factors.

• Personalized Medicine: Increased focus on tailored treatments for individuals.
• Biologics Expansion: Growth in biologic drugs requiring specialized manufacturing.
• Increased R&D Investments: More funding towards research and development in topical drugs.
• Rising Skin Disorder Prevalence: More cases of skin conditions driving demand for treatments.
• Advanced Manufacturing Technologies: Technological advancements enhancing production efficiency.

View More On The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/topical-drugs-contract-development-and-manufacturing-organization-cdmo-global-market-report

Major Trends Shaping the Market
Several trends are expected to shape the market landscape in the coming years.

• Innovative Formulations: Demand for new and effective drug formulations.
• Advancements in Drug Delivery Technologies: Continued innovation in how drugs are delivered.
• Investment in Dermatological Research: Increased funding for research in skin-related treatments.
• Surge in Outsourcing: Pharmaceutical companies increasingly outsourcing to CDMOs.
• Focus on Personalized Medicine: Growing emphasis on customized treatment options.
• Stringent Regulatory Requirements: Need for compliance with complex regulations.
• Consumer Preference for OTC Products: Growing demand for over-the-counter skincare products.

Impact of Rising Skin Disease Prevalence
The increasing prevalence of skin diseases is a significant driver for the market.

• Environmental Factors: Pollution and UV exposure contributing to skin conditions.
• Lifestyle Changes: Modern lifestyle factors leading to higher incidence of skin issues.
• Microbial Infections: Increased cases of infections affecting the skin.
• Targeted Therapies: CDMOs developing targeted treatments to manage and reduce skin diseases.
• Case Study: Significant increase in skin melanoma cases in Australia from 2019 to 2023, highlighting the growing need for effective treatments.

Major Players in the Market
Key companies are driving innovation and growth in the topical drugs CDMO market.

• Notable Companies:
  • Evonik Industries AG
  • Eurofins Scientific SE
  • SGS SA
  • The Lubrizol Corporation
  • Lonza Group AG
  • Catalent Inc.
  • Bora Pharmaceuticals Co. Ltd.
  • Recipharm AB
  • Pierre Fabre S.A.
  • Contract Pharmaceuticals Limited
  • UPM Pharmaceuticals Inc.
  • CoreRx Inc.
  • Halo Pharmaceutical Inc.
  • NextPharma Technologies Holding Limited
  • Tedor Pharma Inc.

Focus on State-of-the-Art Manufacturing Facilities
Companies are investing in advanced manufacturing facilities to stay competitive.

• Example: SOHM Inc. launched a new CDMO GMP manufacturing facility in Carlsbad, enhancing its capacity for manufacturing topical products.

Strategic Acquisitions to Expand Capabilities
Mergers and acquisitions are playing a crucial role in market expansion.

• Example: In April 2024, CoreRx Inc. acquired Societal CDMO Inc. for $130 million, enhancing its CDMO capabilities and market share.

Market Segmentation
The topical drugs CDMO market is segmented by product type, service type, therapeutic area, and end-use.

• Product Type: Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products.
• Service Type: Contract Development, Contract Manufacturing.
• Therapeutic Area: Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas.
• End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses.

Regional Insights
Asia-Pacific was the largest region in the topical drugs CDMO market in 2023, indicating significant regional opportunities for growth.

Request A Sample Of The Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15942&type=smp